Trial Profile
Clinical study of botulinum toxin type A in the treatment of depressive symptoms in patients with Parkinson's disease
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Depressive disorders; Parkinson's disease
- Focus Therapeutic Use
- 21 Jul 2017 New trial record